Panacela Labs, a Subsidiary of Cleveland BioLabs, Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Xenomycins

[at noodls] – Download PDF BUFFALO, N.Y., Nov. 27, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Panacela Labs, Inc. today announced award of a contract valued at 146 million rubles, or approximately … more

View todays social media effects on CBLI

View the latest stocks trending across Twitter. Click to view dashboard